Portfolio Update

RNS Number : 7930C

Intl. Biotechnology Trust PLC

19 November 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

Portfolio update as at 31 October 2009                    

Total Net Assets	£91.9m
NAV per share	141.7p
Share Price	121.8p
Total value of unquoted investments	£18.2m
Total number of portfolio companies	58
Cash	9%
Cash committed and reserved to unquoted investments	15%
Portfolio companies with < 1 year of cash	15%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	7.92	7,276,794
Celgene	6.31	5,799,732
Amgen	5.64	5,180,290
HSBC Sterling Liquid Fund B shares	4.68	4,300,645
Gilead Sciences	4.34	3,984,233
Prime Rate Sterling Liquidity Class 3	3.81	3,502,037
Alexion Pharmaceuticals	3.47	3,188,462
Genzyme	3.06	2,807,900
Wright Medical	2.89	2,652,989
Halozyme Therapeutics	2.24	2,056,948
	-----------	--------------
Total	44.36	40,750,030

Geographical Allocation	%
United States	75
Europe	14
Cash	9
Australia	2
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	71
Unquoted	20
Cash	9
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

19 NOVEMBER 2009

 

END

 

 

PFUBSBDBDBBGGCC